StockNews.com lowered shares of Monroe Capital (NASDAQ:MRCC - Free Report) from a buy rating to a hold rating in a research report released on Monday.
Separately, B. Riley cut Monroe Capital from a "neutral" rating to a "sell" rating and set a $7.25 price target for the company. in a research note on Wednesday, December 11th.
Read Our Latest Analysis on MRCC
Monroe Capital Trading Up 0.7 %
NASDAQ MRCC traded up $0.06 on Monday, hitting $8.16. The company's stock had a trading volume of 33,971 shares, compared to its average volume of 54,306. The company's 50-day moving average is $8.51 and its 200 day moving average is $8.25. The firm has a market cap of $176.79 million, a PE ratio of 13.60 and a beta of 1.03. Monroe Capital has a 1-year low of $6.97 and a 1-year high of $8.85. The company has a quick ratio of 4.37, a current ratio of 4.37 and a debt-to-equity ratio of 1.49.
Monroe Capital Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Friday, March 14th will be given a dividend of $0.25 per share. The ex-dividend date of this dividend is Friday, March 14th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 12.25%. Monroe Capital's payout ratio is presently 166.67%.
Institutional Investors Weigh In On Monroe Capital
Large investors have recently bought and sold shares of the stock. CIBC Private Wealth Group LLC raised its stake in Monroe Capital by 166.0% during the 4th quarter. CIBC Private Wealth Group LLC now owns 10,854 shares of the financial services provider's stock worth $92,000 after buying an additional 6,773 shares during the period. Private Advisor Group LLC acquired a new stake in Monroe Capital in the 3rd quarter valued at $104,000. Envestnet Asset Management Inc. increased its stake in Monroe Capital by 13.3% during the 4th quarter. Envestnet Asset Management Inc. now owns 12,688 shares of the financial services provider's stock valued at $108,000 after purchasing an additional 1,486 shares in the last quarter. Aspiriant LLC raised its holdings in Monroe Capital by 18.2% during the fourth quarter. Aspiriant LLC now owns 13,000 shares of the financial services provider's stock worth $110,000 after buying an additional 2,000 shares during the last quarter. Finally, Strategic Financial Concepts LLC bought a new position in shares of Monroe Capital in the fourth quarter valued at $144,000.
Monroe Capital Company Profile
(
Get Free Report)
Monroe Capital Corporation is a business development company specializing in customized financing solutions in senior, unitranche and junior secured debt, subordinated debt financing and to a lesser extent, unsecured debt and equity, including equity co-investments in preferred and common stock and warrants.
Featured Stories
Before you consider Monroe Capital, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Monroe Capital wasn't on the list.
While Monroe Capital currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
